Related Experiment Videos

Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane

N Garnier1, D Genest, J P Duneau

  • 1Centre de Biophysique Moléculaire, CNRS, Université d'Orleans, France.

Biopolymers
|August 1, 1997
PubMed

Insights

The c-erbB2 transmembrane domains dimerize into left-handed coiled-coil structures. A Glu mutation at position 659 stabilizes these dimers via hydrogen bonds, influencing dimerization in cancer research.

Area of Science:

  • Biophysics
  • Computational Biology
  • Molecular Modeling

Background:

  • The c-erbB2 receptor tyrosine kinase plays a crucial role in cell proliferation and survival.
  • Transmembrane domains are critical for receptor dimerization and signaling.
  • Understanding c-erbB2 transmembrane domain dimerization is key to developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the dimerization models of c-erbB2 transmembrane domains.
  • To analyze the structural and energetic characteristics of wild-type and mutated helices.
  • To elucidate the role of specific mutations in stabilizing dimer formation.

Main Methods:

  • Molecular mechanics simulations.
  • Molecular dynamics simulations.
  • Structural and energetic characterization of dimerization models.

Main Results:

  • Both wild and Glu-mutated transmembrane helices exhibit similar relative orientations for dimerization.
  • Dimerization preferentially occurs in left-handed coiled-coil structures.
  • A Glu mutation at position 659, an interfacing residue, forms symmetric hydrogen bonds that stabilize the dimeric structure.

Conclusions:

  • c-erbB2 transmembrane domains dimerize via a conserved mechanism involving left-handed coiled-coil formation.
  • Specific mutations, like Glu at 659, can enhance dimer stability through hydrogen bonding.
  • These findings provide insights into receptor assembly and potential therapeutic targets in cancer.

Related Concept Videos